Discrimination between Sialic Acid-Containing Receptors and Pseudoreceptors Regulates Polyomavirus Spread in the Mouse

Variations in the polyomavirus major capsid protein VP1 underlie important biological differences between highly pathogenic large-plaque and relatively nonpathogenic small-plaque strains. These polymorphisms constitute major determinants of virus spread in mice and also dictate previously recognized strain differences in sialyloligosaccharide binding. X-ray crystallographic studies have shown that these determinants affect binding to the sialic acids. Here we report results of further experiments designed to test the importance of specific contacts between VP1 and the carbohydrate moieties of the receptor. With minor exceptions, substitutions at positions predicted from crystallography to be important in binding the terminal alpha-2,3-linked sialic acid or the penultimate sugar (galactose) destroyed the ability of the virus to replicate in cell culture. Substitutions that prevented binding to a branched disialyloligosaccharide were found to result in viruses that were both viable in culture and tumorigenic in the mouse. Conversely, substitutions that allowed recognition and binding of the branched carbohydrate chain inhibited spread in the mouse, though the viruses remained viable in culture. Mice of five different inbred strains, all highly susceptible to large-plaque virus, showed resistance to the spread of polyomavirus strains bearing the VP1 type which binds the branched-chain receptor. We suggest that glycoproteins bearing the appropriate O-linked branched sialyloligosaccharide chains are effective pseudoreceptors in the host and that they block the spread of potentially tumorigenic or virulent virus strains.

[1]  R. Bronson,et al.  Radiation-Resistant and Radiation-Sensitive Forms of Host Resistance to Polyomavirus , 1999, Journal of Virology.

[2]  I. Brockhausen,et al.  Glycoproteins and Their Relationship to Human Disease , 1998, Cells Tissues Organs.

[3]  S. Harrison,et al.  High‐resolution structure of a polyomavirus VP1‐oligosaccharide complex: implications for assembly and receptor binding , 1997, The EMBO journal.

[4]  M. Pawlita,et al.  Consequences of a subtle sialic acid modification on the murine polyomavirus receptor , 1997, Journal of virology.

[5]  Young-Choon Lee,et al.  Mouse β-galactoside α2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression , 1997 .

[6]  T. Benjamin,et al.  Roles of N-glycans with alpha2,6 as well as alpha2,3 linked sialic acid in infection by polyoma virus. , 1997, Virology.

[7]  J. Marth Complexity in O-linked oligosaccharide biosynthesis engendered by multiple polypeptide N-acetylgalactosaminyltransferases. , 1996, Glycobiology.

[8]  S. Harrison,et al.  Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. , 1996, Structure.

[9]  S. Harrison,et al.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1 , 1995, Journal of virology.

[10]  H. Kawasaki,et al.  Molecular Cloning of Cytidine Monophospho-N-acetylneuraminic Acid Hydroxylase. REGULATION OF SPECIES- AND TISSUE-SPECIFIC EXPRESSION OF N-GLYCOLYLNEURAMINIC ACID (*) , 1995, The Journal of Biological Chemistry.

[11]  M. Dorf,et al.  Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen , 1995, The Journal of experimental medicine.

[12]  M. Fluck,et al.  Enhancer-mediated role for polyomavirus middle T/small T in DNA replication , 1995, Journal of virology.

[13]  Thilo Stehle,et al.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment , 1994, Nature.

[14]  A. Amalfitano,et al.  Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse. , 1992, Molecular and cellular biology.

[15]  L. Villarreal,et al.  Enhancer dependence of polyomavirus persistence in mouse kidneys , 1992, Journal of virology.

[16]  J. Bergelson,et al.  Identification of the integrin VLA-2 as a receptor for echovirus 1. , 1992, Science.

[17]  L. Villarreal,et al.  Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements , 1991, Journal of virology.

[18]  T. Dubensky,et al.  Polyomavirus replication in mice: influences of VP1 type and route of inoculation , 1991, Journal of virology.

[19]  T. Benjamin,et al.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen , 1991, Journal of virology.

[20]  R. Garcea,et al.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior , 1991, Journal of virology.

[21]  L. Villarreal,et al.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice , 1990, Journal of virology.

[22]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[23]  T. Benjamin,et al.  Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice , 1988, Journal of virology.

[24]  G. Carmichael,et al.  Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles , 1987, Journal of virology.

[25]  D. Talmage,et al.  Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. , 1987, The American journal of pathology.

[26]  R. Colonno,et al.  Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses , 1986, Journal of virology.

[27]  M. Israel,et al.  A determinant of polyomavirus virulence enhances virus growth in cells of renal origin , 1985, Journal of virology.

[28]  J. Paulson,et al.  Sialyloligosaccharide receptors of binding variants of polyoma virus. , 1983, Virology.

[29]  J. Paulson,et al.  Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. , 1981, Virology.

[30]  J. Paulson,et al.  Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. , 1980, Virology.

[31]  C. Dawe,et al.  Tumor induction in transplanted tooth buds infected with polyoma virus. , 1966, Journal of the National Cancer Institute.

[32]  F. Schmidt [POLYOMA VIRUS]. , 1963, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[33]  S. E. Stewart The Polyoma Virus , 1960 .

[34]  L. Law,et al.  STUDIES OF MOUSE POLYOMA VIRUS INFECTION , 1960, The Journal of experimental medicine.

[35]  R. Huebner,et al.  Studies of mouse polyoma virus infection. III. Distribution of antibodies in laboratory mouse colonies. , 1959 .